219 related articles for article (PubMed ID: 15933616)
1. Exenatide (Byetta) for type 2 diabetes.
Med Lett Drugs Ther; 2005 Jun; 47(1210):45-6. PubMed ID: 15933616
[TBL] [Abstract][Full Text] [Related]
2. Exenatide and acute pancreatitis.
Tripathy NR; Basha S; Jain R; Shetty S; Ramachandran A
J Assoc Physicians India; 2008 Dec; 56():987-8. PubMed ID: 19322980
[TBL] [Abstract][Full Text] [Related]
3. [Reply on new drugs against type 2 diabetes: important to gain experience and knowledge].
Sjöholm A; Agardh CD; Brismar K; Efendic S; Eliasson B; Eriksson JW; Frid A; Groop L; Holmgren J; Ridderstråle M; Smith U
Lakartidningen; 2008 Apr 23-May 6; 105(17-18):1310, 1312. PubMed ID: 18561535
[No Abstract] [Full Text] [Related]
4. Exenatide once weekly in type 2 diabetes.
Scheen AJ
Lancet; 2008 Oct; 372(9645):1197-8. PubMed ID: 18782642
[No Abstract] [Full Text] [Related]
5. Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis.
Pinelli NR; Cha R; Brown MB; Jaber LA
Ann Pharmacother; 2008 Nov; 42(11):1541-51. PubMed ID: 18957626
[TBL] [Abstract][Full Text] [Related]
6. [Exenatide (Byetta)].
Duh D; Vandevijver A
J Pharm Belg; 2008 Mar; 63(1):29-30. PubMed ID: 18479081
[No Abstract] [Full Text] [Related]
7. Byetta update: what we've learned from experience.
Cornell S; Todd T
Diabetes Self Manag; 2010; 27(2):28, 30-1. PubMed ID: 20405747
[No Abstract] [Full Text] [Related]
8. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
Sheffield CA; Kane MP; Busch RS
Pharmacotherapy; 2007 Oct; 27(10):1449-55. PubMed ID: 17896900
[TBL] [Abstract][Full Text] [Related]
9. Diabetes quiz. How much do you know about Byetta?
Flannery L
Diabetes Self Manag; 2007; 24(4):52, 54. PubMed ID: 17663084
[No Abstract] [Full Text] [Related]
10. Exenatide: excessive weight loss.
Prescrire Int; 2011 Jan; 20(112):17. PubMed ID: 21462789
[No Abstract] [Full Text] [Related]
11. Exenatide and rare adverse events.
Ahmad SR; Swann J
N Engl J Med; 2008 May; 358(18):1970-1; discussion 1971-2. PubMed ID: 18456920
[No Abstract] [Full Text] [Related]
12. Exenatide in the treatment of diabetic patients with non-alcoholic steatohepatitis: a case series.
Kenny PR; Brady DE; Torres DM; Ragozzino L; Chalasani N; Harrison SA
Am J Gastroenterol; 2010 Dec; 105(12):2707-9. PubMed ID: 21131943
[No Abstract] [Full Text] [Related]
13. Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes.
Kim D; MacConell L; Zhuang D; Kothare PA; Trautmann M; Fineman M; Taylor K
Diabetes Care; 2007 Jun; 30(6):1487-93. PubMed ID: 17353504
[TBL] [Abstract][Full Text] [Related]
14. Extended-release exenatide (Bydureon) for type 2 diabetes.
Med Lett Drugs Ther; 2012 Mar; 54(1386):21-3. PubMed ID: 22421818
[No Abstract] [Full Text] [Related]
15. Molecule of the month. Exenatide.
Drug News Perspect; 2003 Nov; 16(9):621. PubMed ID: 14702143
[No Abstract] [Full Text] [Related]
16. [Exenatide convinces in a six-month study: HbA1c sunk significantly].
MMW Fortschr Med; 2009 May; 151(19):51. PubMed ID: 19827448
[No Abstract] [Full Text] [Related]
17. Beyond glycemic control: the role of incretin hormones.
Ridge TD
J Am Acad Nurse Pract; 2007; 19(11 Suppl 1):11-4. PubMed ID: 18341243
[No Abstract] [Full Text] [Related]
18. Hypoglycemia in patients with type 2 diabetes using concomitant exenatide BID and long-acting insulin therapy.
Pawaskar MD; Blickensderfer AL; Hoogwerf BJ; Quimbo R; Wade R
J Med Econ; 2011; 14(6):705-8. PubMed ID: 21892855
[TBL] [Abstract][Full Text] [Related]
19. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures.
Mack CM; Moore CX; Jodka CM; Bhavsar S; Wilson JK; Hoyt JA; Roan JL; Vu C; Laugero KD; Parkes DG; Young AA
Int J Obes (Lond); 2006 Sep; 30(9):1332-40. PubMed ID: 16534527
[TBL] [Abstract][Full Text] [Related]
20. Acute exenatide (Byetta) poisoning was not associated with significant hypoglycemia.
Cohen V; Teperikidis E; Jellinek SP; Rose J
Clin Toxicol (Phila); 2008 Apr; 46(4):346-7. PubMed ID: 17852164
[No Abstract] [Full Text] [Related]
[Next] [New Search]
